|
Public |
|
| Healthcare & Pharmaceuticals - Medical Devices | |
| over $1B | |
| over 10K | |
| www.varian.com | |
| (650) 493-4000 | |
| (302) 636-5454 | |
Varian Medical Systems Inc. is a manufacturer of medical devices and software for treating cancer and other medical conditions with radiotherapy, radiosurgery, proton therapy and brachytherapy. The Company is a supplier of X-ray imaging components for medical, scientific, and industrial applications and supplies X-ray imaging products for cargo screening and industrial inspection. The Company offers tools for fighting cancer, taking X-ray images and protecting ports and borders. The Company’s products include linear accelerators, brachytherapy afterloaders, treatment simulation and verification equipment, accessories, information management, treatment planning and image processing software. The Company’s customers include university research and community ... (Source: SEC reports)
Competitor - 1/8
Which company is more competitive with Varian Medical Systems?
Oct 6, 2018 01:15:41
PALO ALTO, Calif., Oct. 3, 2018 /PRNewswire/ --Â Varian (NYSE: VAR), today announced it has appointed Kolleen T. Kennedy, formerly president of Varian Oncology Systems (VOS) to a new role as [...]
Sep 13, 2018 05:22:52
PALO ALTO, Calif., Sept. 12, 2018 /PRNewswire/ -- Varian (NYSE : VAR ) today announced that Jeffrey R. Balser, MD, PhD, president and chief executive officer at Vanderbilt University [...]
Sep 14, 2017 20:08:20
ALGIERS, Algeria, Sept. 14, 2017 /PRNewswire/ -- Varian Medical Systems (NYSE: VAR), leader in radiotherapy systems and software for the treatment of cancer, today announced it has begun holding its [...]
Aug 14, 2017 21:37:06
PALO ALTO, Calif., Aug. 14, 2017 /PRNewswire/ --Â Varian Medical Systems (NYSE: VAR), the world leader in radiotherapy and radiosurgery systems and software, will hold a meeting for investors [...]
Aug 10, 2017 20:01:26
PALO ALTO, Calif., Aug. 10, 2017 /PRNewswire/ --Â Varian Medical Systems (NYSE: VAR) today announced it has named J. Michael Bruff as Vice President of Investor Relations effective [...]